Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
EBIATLong-Term Debt IssuancesWages, Salaries and Other
Ratios

Armata Pharmaceuticals (ARMP) Shares Outstanding (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Shares Outstanding for 6 consecutive years, with $5.1 million as the latest value for Q3 2018.

  • Quarterly Shares Outstanding fell 45.69% to $5.1 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Sep 2018, down 45.69% year-over-year, with the annual reading at $5.1 million for FY2017, 207.73% up from the prior year.
  • Shares Outstanding hit $5.1 million in Q3 2018 for Armata Pharmaceuticals, roughly flat from $5.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $277.9 million in Q1 2015 to a low of $1.6 million in Q4 2016.
  • Historically, Shares Outstanding has averaged $30.4 million across 5 years, with a median of $7.5 million in 2015.
  • Biggest five-year swings in Shares Outstanding: plummeted 97.29% in 2016 and later surged 208.24% in 2018.
  • Year by year, Shares Outstanding stood at $8.7 million in 2014, then crashed by 93.22% to $588291.0 in 2015, then surged by 180.26% to $1.6 million in 2016, then skyrocketed by 207.73% to $5.1 million in 2017, then fell by 0.17% to $5.1 million in 2018.
  • Business Quant data shows Shares Outstanding for ARMP at $5.1 million in Q3 2018, $5.1 million in Q2 2018, and $5.1 million in Q1 2018.